G217-1076 Screening compound: N-[4-({[(oxolan-2-yl)methyl]carbamoyl}methyl)phenyl]-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide

G217-1076 Screening compound: N-[4-({[(oxolan-2-yl)methyl]carbamoyl}methyl)phenyl]-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide
G217-1076 Screening compound: N-[4-({[(oxolan-2-yl)methyl]carbamoyl}methyl)phenyl]-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G217-1076
N-[4-({[(oxolan-2-yl)methyl]carbamoyl}methyl)phenyl]-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G217-1076

Molecular Formula

C24H29N3O3 (C24 H29 N3 O3)

Compound Name

N-[4-({[(oxolan-2-yl)methyl]carbamoyl}methyl)phenyl]-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide

IUPAC name

N-[4-({[(oxolan-2-yl)methyl]carbamoyl}methyl)phenyl]-2345-tetrahydro-1H-1-benzazepine-1-carboxamide

SMILES

O=C(Cc(cc1)ccc1NC(N(CCCC1)c2c1cccc2)=O)NCC1OCCC1

InChI

InChI=1S/C24H29N3O3/c28-23(25-17-21-8-5-15-30-21)16-18-10-12-20(13-11-18)26-24(29)27-14-4-3-7-19-6-1-2-9-22(19)27/h1-2,6,9-13,21H,3-5,7-8,14-17H2,(H,25,28)(H,26,29)/t21-/m1/s1

InChI Key

QUFKWWAIXMTWPD-OAQYLSRUSA-N

MDL Number (MFCD)

MFCD14987473

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

407.51

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.203

Distribution Coefficient, logD

3.203

Water Solubility, LogSw

-3.38

Polar Surface Area

57.557

Acid Dissociation Constant (pKa)

13.44

Base Dissociation Constant (pKb)

-0.33

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

41.70

G217-1076 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Targeted Diversity Library (40567 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G217-1076 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G217-1076?
Check Price and Availability of G217-1076, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G217-1076 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G217-1076
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G217-1076
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G217-1076 available by request